Aprea Therapeutics, Inc. (APRE)

Operating Expenses

$13.22M

TTM · Period ending: · USD

APRE logo

APRE Operating Expenses

Latest reported$13.22M
APRE TTM Operating Expenses ($29.54M → $13.22M)
High-resolution chart · PNG

APRE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
13,217,645
10,779,136
9,119,130
7,548,813
6,036,663
6,293,811
6,458,699
7,029,239
7,143,716
6,991,609
8,427,704
8,904,610
10,267,513
100,222,723
104,931,637
110,640,094
116,987,887
35,331,547
37,446,353
43,841,076
46,644,970
51,128,303
52,811,212
50,567,568
45,551,618
37,009,118
29,544,298
22,463,910
18,176,279
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.